Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» non-small cell lung cancer
non-small cell lung cancer
Data on ArQule's Tivantinib
Yahoo/Zacks
Sat, 10/5/13 - 09:18 am
Arqule
tivantinib
Daiichi Sankyo
lung cancer
non-small cell lung cancer
Roche's new round of lung cancer data keeps spotlight on immunotherapies
Fierce Biotech
Mon, 09/30/13 - 05:00 pm
Roche
PD-L1
non-small cell lung cancer
MPDL3280A
lung cancer
With Promising Results, AstraZeneca Targets Mutated Lung Cancer And Rival Clovis Drug
TheStreet.com
Mon, 09/30/13 - 10:31 am
AZD9291
Clovis Oncology
AstraZeneca
CO-1686
non-small cell lung cancer
ARIAD Presents Updated Phase 1/2 Data on AP26113 in Patients with Non-Small Cell Lung Cancer
Yahoo/BusinessWire
Sat, 09/28/13 - 11:57 am
non-small cell lung cancer
Ariad Pharmaceuticals
AP26113
Verastem Initiates Phase 2 Trial of Defactinib in Lung Cancer
Yahoo
Thu, 09/26/13 - 09:48 am
Defactinib
Verastem
non-small cell lung cancer
Infinity Pharma's cancer drug fails mid-stage trial goals
Reuters
Wed, 09/25/13 - 10:41 am
Infinity Pharma
non-small cell lung cancer
retaspimycin
Merck KGaA to continue testing cancer vaccine
Reuters
Wed, 09/25/13 - 08:44 am
vaccines
Merck KGaA
Stimuvax
Oncothyreon
non-small cell lung cancer
Eli Lilly Might Have A Blockbuster Cancer Drug
Seeking Alpha
Tue, 08/27/13 - 10:54 am
Eli Lilly
non-small cell lung cancer
necitumumab
Lilly set to begin critical Alimta patent dispute, WSJ says
The Fly on the Wall
Mon, 08/19/13 - 09:46 am
Eli Lilly
patents
Alimta
non-small cell lung cancer
Cancer Breakthrough Could Mean Big Gains for This Pharma Giant
Yahoo/Street Authority
Wed, 08/14/13 - 09:13 am
lung cancer
Eli Lilly
necitumumab
non-small cell lung cancer
Merck's Pipeline Of Drugs Should Make Up For Lost Sales To Generic Competition
Seeking Alpha
Mon, 08/12/13 - 09:11 am
Merck
generics
lambrolizumab
Odanacatib
melanoma
osteoporosis
non-small cell lung cancer
Ariad Pharma denied FDA's coveted 'breakthrough' stamp for lung cancer drug
Fierce Biotech
Fri, 08/9/13 - 10:00 am
Ariad Pharmaceuticals
FDA
non-small cell lung cancer
AP26113
FDA approves GILOTRIF™ (afatinib) as first-line treatment for metastatic non-small cell lung cancer with common EGFR mutations
Sacramento Bee, CA
Sat, 07/13/13 - 12:37 pm
non-small cell lung cancer
Gilotrif
Afatinib
Boehringer Ingelheim
Roche's Tarceva Progresses in Japan
Yahoo/Zacks
Tue, 06/18/13 - 08:59 am
Japan
Roche
Tarceva
non-small cell lung cancer
Clovis / CO-1686: Value, Derived From Data, Supports The Valuation
Seeking Alpha
Wed, 06/12/13 - 09:07 am
CO-1686
Clovis Oncology
non-small cell lung cancer
Synta Pharmaceuticals: A Promising Biotech Stock for 2013
Motley Fool
Tue, 06/4/13 - 11:13 am
Synta Pharmaceuticals
ganetespib
non-small cell lung cancer
NewLink Genetics Presents Positive Phase 2 Data on Novel Immunotherapy, Tergenpumatucel-L, in Non-Small Cell Lung Cancer at the ASCO 2013 Annual Meeting
Yahoo/PR Newswire
Sat, 06/1/13 - 12:19 pm
NewLink Genetics
tergenpumatucel-L
non-small cell lung cancer
Encouraging News for Peregrine Pharma
Yahoo/Zacks
Sat, 05/25/13 - 11:34 am
Peregrine Pharmaceuticals
bavituximab
non-small cell lung cancer
lung cancer
AstraZeneca Advances Three Cancer Drugs Into Late-Stage Trials
Bloomberg
Thu, 05/16/13 - 10:33 am
AstraZeneca
moxetumomab pasudotox
hairy cell leukemia
olaparib
ovarian cancer
selumetinib
non-small cell lung cancer
Bristol-Myers Has The Future Of Oncology Therapies
Seeking Alpha
Sun, 05/5/13 - 11:00 am
Bristol-Myers Squibb
nivolumab
BMS-936558
non-small cell lung cancer
renal cell carcinoma
melanoma
Ono Pharmaceutical
tivozanib
Aveo Pharmaceuticals
elotuzumab
Pages
« first
‹ previous
…
14
15
16
17
18
19
20
21
22
next ›
last »